Диссертация (1145920), страница 18
Текст из файла (страница 18)
2003. V. 17. (14). P. 1714–26.49. Clavaguera F., Bolmont T., Crowther R.A., Abramowski D., Frank S., ProbstA., Fraser G., Stalder A.K., Beibel M., Staufenbiel M., Jucker M., Goedert M.,Tolnay M. Transmission and spreading of tauopathy in transgenic mouse brain //Nat. Cell Biol. 2009. V. 11. (7). P. 909–913.50. Cohen A., Calkins E. Electron microscopic observations on a fibrous componentin amyloid of diverse origins // Nature.
1959. V. 183. P. 1202–1203.51. Cohen A.S., Calkins E. The Isolation of Amyloid Fibrils and a Study of the Effectof Collagenase and Hyaluronidase. // J. Cell Biol. 1964. V. 21. P. 481–6.52. Colin J., Claubry G. de. Sur les combinaisons de l’iodie avec les substancesvegetales et animals // Ann Chim. 1814. V.
90. P. 87–100.53. Colletier J.-P., Laganowsky A., Landau M., Zhao M., Soriaga A.B., GoldschmidtL., Flot D., Cascio D., Sawaya M.R., Eisenberg D. Molecular basis for amyloidbeta polymorphism. // Proc. Natl. Acad. Sci. U. S. A. 2011. V. 108. (41). P.16938–43.54. Comber T. Real Improvements in Agriculture. London: , 1772.55. Conchillo-Solé O., Groot N.S. de, Avilés F.X., Vendrell J., Daura X., VenturaS. AGGRESCAN: a server for the prediction and evaluation of "hotspots" of aggregation in polypeptides // BMC Bioinformatics.
2007. V. 8.(1). P. 65.56. Cornil A.-V. Sur la dissociation du violet de methytaniline et sa separation endeux couleurs sous l’influence de certain tissues normaux et pathologiques, enparticulier par les tissues en degenerescence amyloide des organs etude au moyende reactifs nouveaux // C. R. Acad Sci. 1875. V.
80. P. 1288–1291.57. Costa P.P., Figueira A.S., Bravo F.R. Amyloid fibril protein related toprealbumin in familial amyloidotic polyneuropathy. // Proc. Natl. Acad. Sci. U.S. A. 1978. V. 75. (9). P. 4499–503.11458. Coustou V., Deleu C., Saupe S., Begueret J. The protein product of the het-sheterokaryon incompatibility gene of the fungus Podospora anserina behaves as aprion analog. // Proc.
Natl. Acad. Sci. U. S. A. 1997. V. 94. (18). P. 9773–8.59. Cox B.S. Ψ, A cytoplasmic suppressor of super-suppressor in yeast // Heredity(Edinb). 1965. V. 20. (4). P. 505–521.60. Cox B.S., Tuite M.F., McLaughlin C.S. The ψ factor of yeast: A problem ininheritance // Yeast. 1988. V. 4.
(3). P. 159–178.61. Cox B.S., Tuite M.F., Mundy C.J. Reversion from suppression tononsuppression in SUQ5 [psi+] strains of yeast: the classificaion of mutations. //Genetics. 1980. V. 95. (3). P. 589–609.62. Crowther R.A., Goedert M. Abnormal Tau-Containing Filaments inNeurodegenerative Diseases // J. Struct. Biol.
2000. V. 130. (2–3). P. 271–279.63. Cuille J., Chelle P.L. Pathologie animale. La maladie dite tremblant du moutonest-elle inoculable? // Compt. Rend. Acad. Sci. 1936. V. 203. P. 1552–1554.64. Cuille J., Chelle P.L. Experimental transmission of trembling to the goat // C. R.Seances Acad. Sci. 1939.
V. 208. P. 1058–1060.65. Derkatch I.L., Bradley M.E., Hong J.Y., Liebman S.W. Prions affect theappearance of other prions: The story of [PIN+] // Cell. 2001. V. 106. (2). P. 171–182.66. Derkatch I.L., Bradley M.E., Zhou P., Chernoff Y.O., Liebman S.W. Geneticand environmental factors affecting the de novo appearance of the [PSI+] prionin Saccharomyces cerevisiae. // Genetics. 1997.
V. 147. (2). P. 507–19.67. Derkatch I.L., Chernoff Y.O., Kushnirov V. V., Inge-Vechtomov S.G., LiebmanS.W. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae// Genetics. 1996. V. 144. (4). P. 1375–1386.68. Derkatch I.L., Uptain S.M., Outeiro T.F., Krishnan R., Lindquist S.L., LiebmanS.W.
Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novoformation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. // Proc.Natl. Acad. Sci. U. S. A. 2004. V. 101. (35). P. 12934–12939.11569. Diederich S., Maisner A. Molecular characteristics of the Nipah virusglycoproteins. // Ann. N. Y. Acad. Sci. 2007. V. 1102. P. 39–50.70.
Dispenzieri A., Gertz M.A., Buadi F. What do I need to know aboutimmunoglobulin light chain (AL) amyloidosis? // Blood Rev. 2012. V. 26. (4). P.137–54.71. Divry P., Florkin M. Sur les prcprietes optiques de l’amyloide // Compt. rend.Soc. Biol. 1927. V.
97. P. 1808–1810.72. Dobson C.M. Protein misfolding, evolution and disease. // Trends Biochem. Sci.1999. V. 24. (9). P. 329–32.73. Doronina V.A., Staniforth G.L., Speldewinde S.H., Tuite M.F., Grant C.M.Oxidative stress conditions increase the frequency of de novo formation of theyeast [PSI+] prion. // Mol.
Microbiol. 2015. V. 96. (1). P. 163–74.74. Douglas P.M., Summers D.W., Ren H.-Y., Cyr D.M. Reciprocal efficiency ofRNQ1 and polyglutamine detoxification in the cytosol and nucleus. // Mol. Biol.Cell. 2009. V. 20. (19). P. 4162–73.75. Douglas P.M., Treusch S., Ren H.-Y., Halfmann R., Duennwald M.L., LindquistS., Cyr D.M. Chaperone-dependent amyloid assembly protects cells from priontoxicity // Proc. Natl.
Acad. Sci. 2008. V. 105. (20). P. 7206–7211.76. Du Z., Li L. Investigating the interactions of yeast prions: [SWI+], [PSI+], and[PIN+]. // Genetics. 2014. V. 197. (2). P. 685–700.77. Du Z., Park K.K.-W., Yu H., Fan Q., Li L. Newly identified prion linked to thechromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. // Nat. Genet.2008. V.
40. (4). P. 460–465.78. Dueholm M.S., Albertsen M., Otzen D., Nielsen P.H. Curli Functional AmyloidSystems Are Phylogenetically Widespread and Display Large Diversity inOperon and Protein Structure // PLoS One. 2012. V. 7. (12). P. e51274.79. Dunn O.J. Multiple Comparisons Using Rank Sums // Technometrics.
1964. V.6. (3). P. 241–252.80. Eanes E.D., Glenner G.G. X-ray diffraction studies on amyloid filaments. // J.Histochem. Cytochem. 1968. V. 16. (11). P. 673–7.11681. Emanuele M., Chieregatti E. Mechanisms of alpha-synuclein action onneurotransmission:cell-autonomousandnon-cellautonomousrole.//Biomolecules.
2015. V. 5. (2). P. 865–92.82. Eriksson M., Schönland S., Yumlu S., Hegenbart U., Hutten H. von, Gioeva Z.,Lohse P., Büttner J., Schmidt H., Röcken C. Hereditary apolipoprotein AIassociated amyloidosis in surgical pathology specimens: identification of threenovel mutations in the APOA1 gene. // J. Mol.
Diagn. 2009. V. 11. (3). P. 257–62.83. Esteras-Chopo A., Serrano L., López de la Paz M. The amyloid stretchhypothesis: recruiting proteins toward the dark side. // Proc. Natl. Acad. Sci. U.S. A. 2005. V. 102. (46). P. 16672–7.84. Família C., Dennison S.R., Quintas A., Phoenix D.A. Prediction of Peptide andProtein Propensity for Amyloid Formation. // PLoS One.
2015. V. 10. (8). P.e0134679.85. Fernandez-Escamilla A.-M., Rousseau F., Schymkowitz J., Serrano L.Prediction of sequence-dependent and mutational effects on the aggregation ofpeptides and proteins // Nat. Biotechnol. 2004. V. 22. (10). P. 1302–1306.86. Fisher R.A. The logic of inductive inference // J. R. Stat. Soc. 1932. V. 98. (1).P. 39–82.87. Fonteyn N. Responsionum et Curationum Medicinalium. Amsterdam:Amstelodami, 1639.88. Fowler D.M., Koulov A.
V., Alory-Jost C., Marks M.S., Balch W.E., Kelly J.W.Functional amyloid formation within mammalian tissue // PLoS Biol. 2006. V. 4.(1). P. 0100–0107.89. Frost B., Jacks R.L., Diamond M.I. Propagation of Tau Misfolding from theOutside to the Inside of a Cell // J. Biol. Chem. 2009. V. 284. (19). P.
12845–12852.90. Frousios K.K., Iconomidou V.A., Karletidi C.-M., Hamodrakas S.J.Amyloidogenic determinants are usually not buried // BMC Struct. Biol. 2009. V.9. (1). P. 44.11791. Funakoshi Y., Doi Y., Hosoda N., Uchida N., Osawa M., Shimada I., TsujimotoM., Suzuki T., Katada T., Hoshino S. Mechanism of mRNA deadenylation:evidence for a molecular interplay between translation termination factor eRF3and mRNA deadenylases.
// Genes Dev. 2007. V. 21. (23). P. 3135–48.92. Gajdusek D.C., Gibbs C.J. Letter: Survival of Creutzfeldt-Jakob-disease virus informol-fixed brain tissue. // N. Engl. J. Med. 1976. V. 294. (10). P. 553.93. Gajdusek D.C., Zigas V. Degenerative disease of the central nervous system inNew Guinea; the endemic occurrence of kuru in the native population.
// N. Engl.J. Med. 1957. V. 257. (20). P. 974–8.94. Gajdusek D.C., Zigas V. Kuru; clinical, pathological and epidemiological studyof an acute progressive degenerative disease of the central nervous system amongnatives of the Eastern Highlands of New Guinea. // Am. J. Med. 1959. V. 26. (3).P. 442–469.95.
Galzitskaya O. V., Garbuzynskiy S.O., Lobanov M.Y. Prediction ofAmyloidogenic and Disordered Regions in Protein Chains // PLoS Comput. Biol.2006. V. 2. (12). P. e177.96. Gerven N. Van, Klein R.D., Hultgren S.J., Remaut H. Bacterial amyloidformation: structural insights into curli biogensis. // Trends Microbiol. 2015. V.23. (11). P. 693–706.97. Ghetti B., Tagliavini F., Masters C.L., Beyreuther K., Giaccone G., Verga L.,Farlow M.R., Conneally P.M., Dlouhy S.R., Azzarelli B. Gerstmann-SträusslerScheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloidcoexist in an affected family. // Neurology.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
